Corporate
News Release
Cameron Groome Joins Bioniche as Executive Vice-President, Corporate & Strategic Development
27/06/06
-- brings transactional and strategic expertise -- BELLEVILLE, ON, June 27, 2006 – Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that Cameron Groome is joining its management team as Executive Vice-President, Corporate & Strategic Development. Mr. Groome joins Bioniche from a major Canadian investment dealer, where he led its life sciences investment banking activities. He is well-known to Canadian life sciences companies and investors, having had success as an equity analyst, industry commentator, investment banker and corporate advisor. Mr. Groome’s experience is comprised of more than 15 years focused on life sciences and includes more than 100 successful capital market and other business transactions for firms in the sector. “Cameron is a great addition to our Executive team,” said Graeme McRae, President and CEO of Bioniche Life Sciences Inc. “He has a broad knowledge of science, biotechnology, health services, and capital markets, all of which will contribute to our strategy for corporate growth. Cameron has recently advised Bioniche on two major transactions, and has consulted on others, demonstrating his skill set first-hand to the Company. We are pleased to have him join us at such an important time in our development – with our proprietary treatment for bladder cancer now entering Phase III clinical trials with fast track status and our proprietary E. coli O157:H7 cattle vaccine in the U.S. regulatory pathway. As these projects near completion, the Company looks forward to continuing to develop its rich pipeline, and Cameron will play a key role in this.” Added Cameron, “After so often acting as an outside advisor, it is a pleasure to be accorded an executive position with so promising a firm. I welcome the opportunity to become part of a very talented team and help drive the creation of lasting value.” ###
|